Abstract
Pancreatic cancer is the fourth most common cause of cancer related death in Western countries. Advantages in surgical techniques, radiation and chemotherapy had almost no impact on the long term survival of affected patients. Therefore, the need for better treatment strategies is urgent. HER2, a receptor tyrosine kinase of the EGFR family, involved in signal transduction pathways leading to cell growth and differentiation is overexpressed in a number of cancers, including breast and pancreatic cancer. While in breast cancer HER2 has already been successfully used as a treatment target, there are only limited data evaluating the effects of inhibiting HER2 tyrosine kinases in patients with pancreatic cancer. Here we report the design of a prospective, non-randomized multi-centered Phase II clinical study evaluating the effects of the Fluoropyrimidine-carbamate Capecitabine (Xeloda) and the monoclonal anti-HER2 antibody Trastuzumab (Herceptin) in patients with non-resectable, HER2 overexpressing pancreatic cancer. Patients eligible for the study will receive Trastuzumab infusions on day 1, 8 and 15 concomitant to the oral intake of Capecitabine from day 1 to day 14 of each three week cycle. Cycles will be repeated until tumor pro...Continue Reading
References
Mar 1, 1989·Controlled Clinical Trials·R Simon
May 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J HjermstadS Kaasa
Mar 3, 1993·Journal of the National Cancer Institute·N K AaronsonJ C de Haes
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H A BurrisD D Von Hoff
Apr 5, 2001·Clinical Pharmacokinetics·B ReignerE Weidekamm
May 2, 2001·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·P BüchlerO J Hines
Oct 5, 2001·American Journal of Clinical Oncology·H SafranU Tantravahi
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas H CartwrightJoseph J Schulz
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Viviane HessRichard Herrmann
Feb 11, 2003·Seminars in Oncology·Volker Heinemann
Mar 19, 2004·The New England Journal of Medicine·John P NeoptolemosUNKNOWN European Study Group for Pancreatic Cancer
May 20, 2004·Journal of the National Cancer Institute·Mark D PegramDennis J Slamon
Dec 8, 2004·Cancer Investigation·Howard SafranTeresa Kennedy
Jul 21, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Megan Dann FesinmeyerDeborah J Bowen
Jan 19, 2006·Cancer Chemotherapy and Pharmacology·Søren Astrup Jensen, Jens Benn Sørensen
Aug 18, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kenjiro KimuraKosei Hirakawa
Mar 16, 2007·Neoplasia : an International Journal for Oncology Research·Peter BüchlerOscar J Hines
Jun 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard HerrmannUNKNOWN Central European Cooperative Oncology Group
Jun 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Asma SultanaPaula Ghaneh
Aug 7, 2007·Cancer·Jamael El FitoriHelmut Friess
Oct 27, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S BoeckV Heinemann
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Mar 6, 2008·JAMA : the Journal of the American Medical Association·William F RegineTyvin A Rich
Aug 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jürg BernhardUNKNOWN Central European Cooperative Oncology Group
Mar 30, 2013·BMC Cancer·Fanxing HongDonna L Berry
Citations
Jun 22, 2010·TheScientificWorldJournal·Patrick ChamesDaniel Baty
Mar 4, 2010·The AAPS Journal·Jing LiJessie L-S Au
Jul 27, 2010·Human Pathology·Andreas H MarxJakob R Izbicki
Sep 8, 2019·International Journal of Molecular Sciences·Hongmei XiaoXinjian Chen